Results 111 - 120 of 122
Researchers
| Name | Track | Location | View profile |
|---|---|---|---|
| Regenerative Science | Florida | ||
IntroductionWenchun Qu, M.D., Ph.D., is a professor of anesthesiology and a professor of PM&R at Mayo Clinic Alix School of Medicine. He is board-certified in PM&R and Pain Medicine and is a consultant at the Department of Pain Medicine. He serves as the Jorge and Leslie Bacardi associate director for Mayo Clinic Center for Regenerative Biotherapeutics in Florida, vice-chair of Research and Innovation at the Department of Pain Medicine, and director of Regenerative Pain Medicine. Dr. Qu’s discovery research builds the platform of RNA and EV engineering for the delivery of biotherapeutics addressing inflammatory and cancer processes. His translational study focuses on clinical trials of cell and RNA therapy for degenerative disc disease and spinal cord injury. |
|||
| Neuroscience | Florida | ||
IntroductionDr. Wolfdieter Springer studies how brain cells change with aging and in neurodegeneration. His lab explores why some cells are more vulnerable than others and how strengthening protective cellular systems may promote health. Using multidisciplinary approaches, his team examines processes involving mitochondria, lysosomes, and protein quality control. By combining basic and translational research, they aim to better understand disease and resilience mechanisms and support the development of new biomarkers and treatments for metabolic and age-related disorders. Dr. Springer is dedicated to a welcoming, inclusive, and supportive lab environment and enjoys mentoring students to build curiosity, confidence, critical thinking, and independence. |
|||
| Biochemistry and Molecular Biology | Minnesota | ||
IntroductionDr. Xiaogang Li is a Professor and Consultant in the Department of Biochemistry and Molecular Biology. He directs the Epigenetics, Inflammation and Gene Therapy of Kidney Diseases Laboratory, where his group investigates the molecular mechanisms underlying polycystic kidney disease (PKD), breast cancer, ciliopathies, and aging, with the overarching goal of developing novel therapeutic approaches. Dr. Li has mentored eight PhD students to completion and trained over 30 postdoctoral fellows. He currently serves as Associate Director of the Mayo Clinic Robert M. and Billie Kelley Pirnie Translational Polycystic Kidney Disease (PKD) Center, and Vice Chair of Research for the Division of Nephrology and Hypertension. |
|||
| Biochemistry and Molecular Biology | Minnesota | ||
IntroductionDr. Xiaolei Xu is a consultant and professor in the Department of Biochemistry and Molecular Biology with a joint appointment in the Department of Cardiovascular Diseases. He is a co-leader of the Cardiovascular Aging Program, Robert & Arlene Kogod Center on Aging, Mayo Clinic. Dr. Xu directs the Zebrafish Genetics laboratory, where his group leverages powerful genetic tools offered by this vertebrate animal to decipher mechanisms of cardiomyopathy and to seek novel therapies. More recently, he integrated African Turquois Killifish (ATK), a vertebrate with the shortest lifespan that can be bred in captivity, into his research, aiming to decipher cardiac aging and to discover novel gerotherapeutics to improve healthspan and lifespan. |
|||
| Biomedical Engineering and Physiology, Clinical and Translational Science | Minnesota | ||
IntroductionYash Singh, Ph.D., is an assistant professor of radiology at Mayo Clinic College of Medicine and Science. He earned degrees in informatics, and biomedical engineering from India and Taiwan, supported by government scholarships, and completed a DAAD fellowship in Germany. He has held visiting roles at Harvard and Brigham and Women’s Hospital and received awards from NIH, Stanford, and NYAS. Dr. Singh develops AI and machine learning methods for medical imaging, focusing on interpretability, large language models, and imaging biomarkers in liver disease and cancer. He has published widely, collaborates globally, serves on multiple editorial boards, and received RSNA Research Trainee Awards in 2024 and 2025. |
|||
| Biomedical Engineering and Physiology | Minnesota | ||
IntroductionDr. Yuguang Liu, Ph.D., is an Assistant Professor of Biomedical Engineering at Mayo Clinic in Rochester, Minnesota, where she leads the Integrated Microfluidics and Microsensors Laboratory. Her research sits at the intersection of engineering, medicine, and clinical translation, using microfluidic technologies to study cell-cell interactions, cancer progression, and therapeutic response. Dr. Liu offers a multidisciplinary environment that values curiosity, technical rigor, collaboration, and patient-centered innovation. Potential mentees interested in bioengineering, single-cell biology, diagnostics, therapeutic monitoring, or translational technology development will find opportunities to ask bold questions and build tools with clinical impact. |
|||
| Biochemistry and Molecular Biology | Minnesota | ||
IntroductionDr. Liu is a human geneticist with extensive experience in the area of human genetics, functional genomics, bioinformatics, epigenomics, and disease modeling with glaucoma and corneal disorders, funded by NIH/NEI and private foundations since 2010 (more than 180 publications). Our research focuses on dissecting the genetic and environmental interaction by integrating biomechanical stretching, hormonal factors, epigenetic remodeling, and advanced experimental technologies. Dr. Liu has successfully mentored four Ph.D. students and is mentoring four doctoral students now. Two students have received NIH/NEI F31 predoctoral fellowship awards. We apply multi-omic approaches with human patient samples, animal models, and ex vivo/in vitro cellular/tissue models. |
|||
| Molecular Pharmacology and Experimental Therapeutics | Minnesota | ||
IntroductionZhenkun Lou, Ph.D., is a Professor of Pharmacology, co-leader of the Experimental Therapeutics Program at the Mayo Clinic Cancer Center in Rochester, Minnesota. His lab focuses on signaling pathways that are activated by DNA damage-inducing radiation and chemotherapy. DNA damage activates a signaling cascade called the DNA damage response (DDR) pathway that initiates DNA repair and cell cycle checkpoint activation. Understanding this pathway will elucidate the cause of genomic instability, a driving force of tumorigenesis. His lab has been studying the DNA repair pathway for 20 years and is an internationally known leader in the field. He is the Swanson/Schmucker Endowed Professor of Cancer Research and was elected as an AAAS fellow. |
|||
| Biochemistry and Molecular Biology | Arizona | ||
IntroductionDr. Sun’s lab develops computational and bioinformatics approaches to advance precision medicine through the integration of genomics, epigenomics, transcriptomics, and multi-omics data. We use next-generation sequencing, single-cell technologies, machine learning, and AI to uncover disease mechanisms, identify biomarkers, and develop predictive models. Current research includes liquid biopsy for early cancer detection, DNA methylation-based multi-cancer detection, multi-omics integration, regulatory genomics, autoimmune diseases, and bioinformatics method development. Students work with large clinical and molecular datasets in collaborative translational research that bridges biology and patient care. |
|||
| Biomedical Engineering and Physiology | Minnesota | ||
IntroductionDr. Zhongxing Zhou is a Research Scientist and Associate Professor of Radiology at Mayo Clinic. His research integrates CT physics, artificial intelligence, and virtual imaging trials to advance low-dose and photon-counting detector (PCD) CT imaging. Key focus areas include deep learning-based denoising, spatial resolution enhancement for interstitial lung disease, hallucination mitigation, comprehensive image quality assessment (MTF, NPS, lesion detectability), and multi-energy/dynamic 4D CT techniques. With more than 60 publications (Editor’s Choice awards), patents, RSNA honors, and Associate Editor role for Medical Physics, Dr. Zhou mentors motivated students in medical imaging and AI who are independent and collaborative. |
|||